Quotes 5-day view Delayed Nyse
01/11/2021
01/12/2021
01/13/2021
01/14/2021
01/15/2021
Date
159.25(c)
151.98(c)
151.52(c)
148.13(c)
148.52(c)
Last
1 316 447
1 389 433
1 111 192
859 481
824 867
Volume
-0.32% -4.57% -0.30% -2.24% +0.26% Change
Sales 2020
3 602 M - -
Net income 2020
619 M - -
Net Debt 2020
1 463 M - -
P/E ratio 2020
26,9x
Yield 2020
0,19%
Sales 2021
4 121 M - -
Net income 2021
753 M - -
Net Debt 2021
549 M - -
P/E ratio 2021
22,1x
Yield 2021
0,19%
Capitalization
16 630 M 16 630 M -
EV / Sales 2020
5,02x
EV / Sales 2021
4,17x
Nbr of Employees
13 000
Free-Float
99,2%
PerkinElmer, Inc. specializes in designing, manufacturing, and marketing measurement devices and analytical instruments for the healthcare, environmental, scientific research, industry and food sectors. Net sales (before intra-group eliminations) break down by family of products as follows :
- analytical tools and instruments (60.6%): biological molecular research tools, thermal analysis software, chemical and...
Notations Surperformance© of PerkinElmer, Inc.
Trading Rating : Investor Rating :
All news about PERKINELMER, INC.
News in other languages on PERKINELMER, INC.
Analyst Recommendations on PERKINELMER, INC.
PERKINELMER, INC. - 01/06
The revival in interest should continue
BUY
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends PERKINELMER, INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
16
Average target price
152,33 $
Last Close Price
148,52 $
Spread / Highest target
29,9%
Spread / Average Target
2,57%
Spread / Lowest Target
-33,3%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
